HYPR
NASDAQHyperfine Inc.
News · 26 weeks49+38%
2025-12-142026-06-07
Mix3490d
- Insider12(35%)
- SEC Filings11(32%)
- Other7(21%)
- Earnings2(6%)
- Offering1(3%)
- M&A1(3%)
Latest news
25 items- INSIDERSEC Form 4 filed by Director Wolterman Dan4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERCFO and CAO Hale Brett sold $9,978 worth of shares (6,047 units at $1.65), decreasing direct ownership by 1.00% to 599,765 units (SEC Form 4)4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERChief Operating Officer Teisseyre Thomas sold $9,978 worth of shares (6,047 units at $1.65), decreasing direct ownership by 0.88% to 678,601 units (SEC Form 4) (withholding obligation)4 - Hyperfine, Inc. (0001833769) (Issuer)
- PRHyperfine to Join Russell 2000® and Russell 3000® IndexesHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system— today announced that Hyperfine is expected to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the June 2026 Russell Reconstitution, according to a preliminary list of additions posted by FTSE Russell on May 22, 2026. Hyperfine's inclusion will become effective after the U.S. market close on June 26, 2026. The June reconstitution of the Russell US indexes captures up to the 4,000 largest U.S. stocks as of April 30, ranking them by total mark
- INSIDERSEC Form 4 filed by Director Fattori Ruth A4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERSEC Form 4 filed by Director Wolterman Dan4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERSEC Form 4 filed by Director Dahldorf John T4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERSEC Form 4 filed by Director Rothberg Jonathan M4 - Hyperfine, Inc. (0001833769) (Issuer)
- PRHyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency DepartmentsProspective randomized ED study shows rapid bedside imaging, detection of critical neurological findings, and potential workflow efficiency benefits with portable MRI Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the presentation of results of the PRIME (Portable Rapid Imaging for Medical Emergencies) study at the Society for Academic Emergency Medicine (SAEM) 2026 Annual Meeting. PRIME is a single-center, prospective, randomized controlled trial designed to evaluate the role of portable MRI in neurological emergencies i
- SECSEC Form EFFECT filed by Hyperfine Inc.EFFECT - Hyperfine, Inc. (0001833769) (Filer)
- SECHyperfine Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Hyperfine, Inc. (0001833769) (Filer)
- SECSEC Form S-3 filed by Hyperfine Inc.S-3 - Hyperfine, Inc. (0001833769) (Filer)
- SECSEC Form 10-Q filed by Hyperfine Inc.10-Q - Hyperfine, Inc. (0001833769) (Filer)
- SECHyperfine Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Hyperfine, Inc. (0001833769) (Filer)
- PRHyperfine, Inc. Reports First Quarter 2026 Financial ResultsHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update. "Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating commercial engine. We believe the international regulatory clearances we secured, the clinical data we released to the neurology and stroke communities, and the continued momentum in our office and hospital businesses all indicate p
- PRHyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare ConferenceHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming 2026 Jefferies Global Healthcare Conference on Thursday, June 4th at 8:45 am Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.'s corporate website at https://investors.hyperfine.io. Management will also be hosting in-person meetings. To schedule a one-on-one meeting with management, please reach out to your Jefferies representative, or the investor contact be
- ANALYSTBTIG Research initiated coverage on Hyperfine with a new price targetBTIG Research initiated coverage of Hyperfine with a rating of Buy and set a new price target of $2.00
- PRHyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical InstitutionThe All India Institute of Medical Sciences, New Delhi, in partnership with Radiosurgery Global India, begins clinical use of the Hyperfine Swoop® portable MRI system Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—and the All India Institute of Medical Sciences (AIIMS), New Delhi, India's foremost medical institution, today announced that AIIMS New Delhi has initiated clinical use of the Swoop® portable MRI system. AIIMS New Delhi is the first hospital in India to deploy bedside MRI for routine clinical use, marking an important milestone
- PRHyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the first quarter 2026 on Tuesday, May 12, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.'s corporate website at https://investors.hyperfine.io/. Participants are encouraged to register more than 15 minutes before the start of the call. For more information
- PRHyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ SoftwareThis milestone unlocks Hyperfine's most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality and a major expansion of clinical capability for European markets Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced it has received CE Marking and UK Conformity Assessment (UKCA) approval for both the next-generation Swoop® system and the latest advancement in its Optive AI™ software. Together, these regulatory approvals enable com
- SECSEC Form DEFA14A filed by Hyperfine Inc.DEFA14A - Hyperfine, Inc. (0001833769) (Filer)
- SECSEC Form DEF 14A filed by Hyperfine Inc.DEF 14A - Hyperfine, Inc. (0001833769) (Filer)
- INSIDERSEC Form 4 filed by Hale Brett4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERSEC Form 4 filed by Teisseyre Thomas4 - Hyperfine, Inc. (0001833769) (Issuer)
- INSIDERSEC Form 4 filed by Sainz Maria4 - Hyperfine, Inc. (0001833769) (Issuer)
HYPR FAQ
7 questionsWhat does Hyperfine Inc. do?
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.Where does HYPR stock trade?
Hyperfine Inc. (HYPR) is listed on NASDAQ.What sector and industry is HYPR in?
Hyperfine Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Hyperfine Inc. go public?
Hyperfine Inc. (HYPR) completed its IPO in 2021.What are analysts saying about HYPR?
Hyperfine Inc. has had 4 recent analyst actions on file. The most recent action was from BTIG Research: Buy with a $200.00 price target on 2026-04-29. Recent price targets range from $200.00 to $800.00.What companies are similar to HYPR?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare HYPR side-by-side with any of them on Quantisnow.How can I track HYPR on Quantisnow?
Quantisnow aggregates Hyperfine Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HYPR to receive live email and push alerts on every new disclosure.